Risk‐Stratified and Response‐Adapted Therapy for Pediatric Hodgkin Lymphoma in Argentina: The GATLA Experience

Advances in Hematology · Published 2025-01-01 · DOI 10.1155/ah/5453729

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1155/ah/5453729

Abstract

Conclusion: The international cooperation made it possible to significantly improve the outcomes of patients with advance disease in Argentina compared with our previous experience (7-PHD-96: COPP–ABV × 6 + IFRT Bulky Disease or PR (20/25 Gy): 5yOS: 85%, 5yEFS: 67%), reduce the number of patients who required radiotherapy, and reproduce the European experience for HR patients in a totally different context.

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year
2025

Related articles